Table 1 Mechanism of MSCs resistance to apoptosis.
From: The dual role of mesenchymal stem cells in apoptosis regulation
Pathways | Molecules | Mechanisms | Refs |
---|---|---|---|
Mitochondrial pathway | IL-6 | Via the activation of the JAK-STAT3-Ref-1 and JAK-Stat3-Bcl-2/Bax-Caspase-3 pathways; Upregulate the mRNA expression of Cyclin D and Bcl-xl | |
PGE2 | Via ERK1/2 and GSK3beta phosphorylation to increase Bcl-2 and decrease Bax expression | [29] | |
TGF-β | Through TGF-β/Bax singling pathway | [30] | |
miR-29a-3p | Regulate Bcl-2 and Bcl-xl genes | [31] | |
miR-125b-5p | Repress the protein expression of p53, leading to the modulation of Bcl-2 and Bax to inhibit apoptosis | [32] | |
miR-93 | Through targeting the HDAC4/Bcl-2 axis | [33] | |
miR-150-5p | Via targeting Bax | [34] | |
lncRNA-UCA1 | Target miR-873 via sponging, reducing the latter’s suppressive effects on its target XIAP, and this translated into AMPK phosphorylation and increased level of the antiapoptotic protein Bcl-2 | [35] | |
 | Enhance translocation of Bcl-2 to the nucleus | [36] | |
CXCL12 | Reduce caspase-3 activation and modulate the expression of the antiapoptotic protein Bcl-xl | [38] | |
 | Upregulate p-AKT and p-Bad by PI3K-AKT-Bad pathway | [39] | |
Death receptor pathway |  | Suppress the protein expression levels of macrophage-related factors inducible nitric oxide synthase and TNF-α | [40] |
miR-21-5p | Modulate Fas-L expression | [41] | |
miR-17 | Regulate BRD4-mediated EZH2/TRAIL axis to essentially inhibit LPS-induced macrophages inflammation and apoptosis | [42] | |
 | Via TLR3-regualted MAPK and NF-κB signaling pathway | [43] | |
Endoplasmic reticulum pathway | HGF | Via a microenvironment-dependent paracrine HGF/c-Met signaling mechanism to suppress ERS and its downstream pro-inflammatory and pro-apoptotic consequences | [44] |
TNF-inducible gene 6 protein | Suppress ERS-induced apoptosis and NF-κB activity | [45] | |
miR-21 | By alleviating ERS and inhibiting p38 MAPK | [46] | |
 | By improving Myc expression through both stromal cell-derived factor 1 signal and contact effect | [47] | |
Upstream regulatory pathways | miR-29b-3p | Activate the PI3K/AKT pathway by carrying miR-29b-3p into neurons and silencing PTEN, thus reducing neuronal apoptosis | [49] |
miR-223 | Inhibit the apoptosis of neurons in vitro by targeting PTEN, thus activating the PI3K/Akt pathway | [50] | |
miR-144 | Inhibit cell apoptotic injury in hypoxic conditions by delivering miR-144 to cells, where it targets the PTEN/AKT pathway | [51] | |
miR-486-5p | By suppressing PTEN expression, activating the PI3K/AKT signaling pathway, and subsequently inhibiting the apoptosis of injured cardiomyocytes | [52] | |
lncRNA-KLF3-AS1 | Inhibit autophagy and apoptosis of IL-1beta-treated chondrocyte through PI3K/Akt/mTOR signaling pathway | [53] | |
miR-132-3p | Downregulate the target protein RASA1, while upregulate the expression of Ras and the downstream PI3K phosphorylation | [54] | |
 | Involve NRG-1/HER2, MAPK, PI3K/AKT, p-JNK/JNK, and p-STAT/STAT signaling pathways | [162] | |
 | Involve G-CSF/PI3K/AKT pathway | [163] | |
 | By inhibiting apoptosis of skin cells and promoting their proliferation through activating PI3K/AKT signaling pathway | [164] | |
miR-369-3p | Downregulate the expression of YAF2, inhibit the stability of PDCD5/p53, and reduce the apoptosis of ovarian granulosa cells | [55] | |
miR-644-5p | Inhibit the apoptosis of ovarian granulosa cell by targeting p53 | [56] | |
miR-125b-5p | Suppress the expression of the pro-apoptotic genes p53 and BAK1 in cardiomyocytes | [57] | |
miR-455-3p | Target the MEKK1-MKK4-JNK signaling pathway | [58] | |
miR-19a | Target SOX6, activate AKT, and inhibit JNK3/caspase-3 activation | [59] | |
 | By inhibiting p38/MAPK pathway | ||
Others | Â | By transferring mitochondria | |
 | Increase the mitochondrial membrane potential and alleviate compression-induced mitochondrial damage to alleviate compression-mediated nucleus pulposus cell apoptosis | [65] | |
 | Retard mitochondria damage and cell apoptosis by an AMPK-PGC1-alpha axis | [66] | |
 | Promote mitophagy and inhibit apoptosis and pyroptosis of renal tubular epithelial cells in kidney tissues by upregulating SIRT1/Parkin | [67] | |
 | By reduce mitochondrial reactive oxygen species overproduction, decrease the accumulation of mitochondrial fragmentation, restore ATP generation and upregulate mitophagy | [68] | |
miR-486 | Reduce Smad1 expression by target regulating Smad1 whose reduction could inhibit mTOR activation, leading to the increase of autophagy and the reduction of podocyte apoptosis | [69] | |
 | Through regulating Notch2/mTOR/autophagy signaling | [70] | |
miR-217 | Target EZH2, and EZH2 bound to the FOXO3 promoter and consequently downregulate its expression, which restrain NPC apoptosis and ECM degradation by stimulating cell autophagy | [71] | |
ALKBH5 | ALKBH5-mediated FIP200 mRNA demethylation in enhancing autophagy and reducing apoptosis | [72] | |
 | Reduce pyroptosis in the injured liver and promote the expression of those factors related to liver regeneration, while they can inhibit the NF-κB pathway and activate the wnt/beta-catenin pathway | [73] | |
 | Increase FOXO3a expression to enhance mitophagy, therefore protecting microglia from I/R-induced pyroptosis and alleviating subsequent neuronal injury | [74] | |
miR-539-5p | Suppresses pyroptosis through NLRP3/caspase-1 signal | [75] | |
circ-HIPK3 | By regulate miR-421, resulting in increased expression of FOXO3a, leading to inhibition of pyroptosis and release of IL-1beta and IL-18 | [76] | |
miR-223-3p | Restrict cardiac inflammation, pyroptosis, and dysfunction by disrupting FOXO3/NLRP3 axis | [77] | |
miR-26a-5p | Degrade METTL14 and thus decrease NLRP3 | [78] | |
circ-003564 | Attenuate inflammasome-related pyroptosis via delivering circ-003564 | [79] |